131 related articles for article (PubMed ID: 15342170)
1. Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study.
Sundström J; Evans JC; Benjamin EJ; Levy D; Larson MG; Sawyer DB; Siwik DA; Colucci WS; Wilson PW; Vasan RS
Eur Heart J; 2004 Sep; 25(17):1509-16. PubMed ID: 15342170
[TBL] [Abstract][Full Text] [Related]
2. Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.
Hansson J; Lind L; Hulthe J; Sundström J
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):297-303. PubMed ID: 19387352
[TBL] [Abstract][Full Text] [Related]
3. Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study.
Sundström J; Evans JC; Benjamin EJ; Levy D; Larson MG; Sawyer DB; Siwik DA; Colucci WS; Sutherland P; Wilson PW; Vasan RS
Circulation; 2004 Jun; 109(23):2850-6. PubMed ID: 15173025
[TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.
Tayebjee MH; Nadar SK; MacFadyen RJ; Lip GY
Am J Hypertens; 2004 Sep; 17(9):770-4. PubMed ID: 15363818
[TBL] [Abstract][Full Text] [Related]
5. Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure.
Spoto B; Testa A; Parlongo RM; Tripepi G; D'Arrigo G; Mallamaci F; Zoccali C
Nephrol Dial Transplant; 2012 Jun; 27(6):2440-5. PubMed ID: 22199358
[TBL] [Abstract][Full Text] [Related]
6. Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study.
Sundström J; Sullivan L; Selhub J; Benjamin EJ; D'Agostino RB; Jacques PF; Rosenberg IH; Levy D; Wilson PW; Vasan RS;
Eur Heart J; 2004 Mar; 25(6):523-30. PubMed ID: 15039133
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.
Kosmala W; Plaksej R; Przewlocka-Kosmala M; Kuliczkowska-Plaksej J; Bednarek-Tupikowska G; Mazurek W
Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study.
Dhingra R; Pencina MJ; Benjamin EJ; Levy D; Larson MG; Meigs JB; Rifai N; D'Agostino RB; Vasan RS
Am J Hypertens; 2004 Oct; 17(10):891-6. PubMed ID: 15485750
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen and preclinical echocardiographic target organ damage: the strong heart study.
Palmieri V; Celentano A; Roman MJ; de Simone G; Lewis MR; Best L; Lee ET; Robbins DC; Howard BV; Devereux RB
Hypertension; 2001 Nov; 38(5):1068-74. PubMed ID: 11711499
[TBL] [Abstract][Full Text] [Related]
11. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension.
Lindsay MM; Maxwell P; Dunn FG
Hypertension; 2002 Aug; 40(2):136-41. PubMed ID: 12154103
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study.
Palmieri V; Wachtell K; Bella JN; Gerdts E; Papademetriou V; Nieminen MS; Dahlöf B; Roman MJ; Devereux RB
J Hum Hypertens; 2004 Jun; 18(6):423-30. PubMed ID: 15002006
[TBL] [Abstract][Full Text] [Related]
13. Hyperuricemia and the echocardiographic measures of myocardial dysfunction.
Krishnan E; Hariri A; Dabbous O; Pandya BJ
Congest Heart Fail; 2012; 18(3):138-43. PubMed ID: 22587743
[TBL] [Abstract][Full Text] [Related]
14. Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study.
Vasan RS; Evans JC; Benjamin EJ; Levy D; Larson MG; Sundstrom J; Murabito JM; Sam F; Colucci WS; Wilson PW
Hypertension; 2004 May; 43(5):957-62. PubMed ID: 15007028
[TBL] [Abstract][Full Text] [Related]
15. Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham Heart Study.
Szmigielski C; Raczkowska M; Styczynski G; Pruszczyk P; Gaciong Z
Eur Heart J; 2005 Feb; 26(4):418; author reply 418-9. PubMed ID: 15671046
[No Abstract] [Full Text] [Related]
16. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).
Bonnema DD; Webb CS; Pennington WR; Stroud RE; Leonardi AE; Clark LL; McClure CD; Finklea L; Spinale FG; Zile MR
J Card Fail; 2007 Sep; 13(7):530-40. PubMed ID: 17826643
[TBL] [Abstract][Full Text] [Related]
17. Sex-related differences in relations of uric acid to left ventricular hypertrophy and remodeling in Japanese hypertensive patients.
Kurata A; Shigematsu Y; Higaki J
Hypertens Res; 2005 Feb; 28(2):133-9. PubMed ID: 16025740
[TBL] [Abstract][Full Text] [Related]
18. The impact of hypertension and hypertension-related left ventricle hypertrophy on right ventricle function.
Tumuklu MM; Erkorkmaz U; Ocal A
Echocardiography; 2007 Apr; 24(4):374-84. PubMed ID: 17381646
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Tayebjee MH; Nadar S; Blann AD; Gareth Beevers D; MacFadyen RJ; Lip GY
Am J Hypertens; 2004 Sep; 17(9):764-9. PubMed ID: 15363817
[TBL] [Abstract][Full Text] [Related]
20. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.
Yan AT; Yan RT; Spinale FG; Afzal R; Gunasinghe HR; Arnold M; Demers C; McKelvie RS; Liu PP
J Card Fail; 2006 Sep; 12(7):514-9. PubMed ID: 16952784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
